Doxycycline hyclate is a low-dose tetracycline analog lacking antimicrobial activity, and it is indicated for the treatment of periodontal disease, acting by inhibiting the mechanisms of the MMP-8 and MMP-13 protease. This evidence concerns the gene MMP8 and periodontal disorder.